dm·PRODUCT DESIGNER
MONTRÉAL, CANADA
Back to selected work

02 / MEDICATION ROUTINES · INDEPENDENT PROTOTYPE

Dose.

Make the next step clear.
Make the record understandable.

A medication companion exploring daily routines, dose records and refill planning. An exploratory user study now identifies priorities for the next prototype iteration.

My contribution
Concept, inspiration & research collection
AI contribution
App and interface build
Stage
Existing prototype + early user research
Validation
Early survey findings; usability testing next

Evidence to date: 21 completed survey responses and an existing interactive prototype. The prototype screens were captured on 8 October 2026; the research report is dated 13 October 2026. The findings guide the next iteration. Usability, accessibility outcomes and medication-adherence improvements remain unvalidated.

Explore the prototype
01 / CONCEPTION

A schedule is not
a record of what happened.

I originated Dose as a way to make planned medication routines and recorded actions easier to understand. The initial concept explored schedules, dose history and optional support; survey findings sharpen the priorities for reminders and refill planning.

Initial task

Review today’s schedule, record a dose and check or correct its history.

Initial hypothesis

Separating planned doses from recorded actions may clarify what happened. The survey now provides a reason to test this: 14/20 respondents rely on recall to check a dose.

Scope boundary

Support a personal routine. Clinical guidance, dependable notifications and secure shared access require separate validation; the survey does not establish their effectiveness.

02 / WIREFRAMING & STRUCTURE

Organize the routine.
Then refine the flow.

Today, Medications, History and Profile document the existing prototype’s structure. Use this baseline to explore the research priorities in the next wireframing pass: habit-based reminders, a quick dose-history check and a refill overview.

Dose information architecture showing main destinations and proposed additions
Existing information architecture, including proposed completion paths. This documents the prototype; it does not demonstrate a completed research-led redesign. Future ideas shown in the diagram, such as appointments and wearables, are not validated survey requirements.
Reconstructed screen reference — provenance
Reconstructed Dose screen reference
Illustrative reconstruction from the designer handoff, not a dated original low-fidelity wireframe. Actual prototype captures appear in the next section.

Remember & confirm

Explore reminders around familiar activities and a visible recent-dose record. This responds to routine-based remembering (15/20) and reliance on recall (14/20).

Plan refills ahead

Sketch separate refill dates and editable supply estimates together. Low supply prompts 19/20 to refill; 5/14 written difficulty responses describe refill logistics.

Handle changed routines

Explore travel and busy-day flows alongside physical organizers. Six of 18 travel responses mention an organizer. Evaluate optional support separately.

Wireframing status: the available materials document structure and a reconstructed reference. Original low-fidelity wireframes and a completed iteration based on this survey are not evidenced here.

03 / PROTOTYPING

Review. Record.
Check the history.

The AI-built prototype makes the core review → record → history flow tangible. These captures use fictional study data and were taken on 8 October 2026, before the 13 October research report. They form a baseline for testing the needs identified in the survey.

Dose Today screen with scheduled medication and recording controls
1 / Review · Today groups scheduled tasks and attention items.
Dose recorded state with timestamp and Undo feedback
2 / Record · The occurrence moves to recorded items and exposes Undo.
Dose History screen showing the recorded occurrence
3 / Inspect · History distinguishes scheduled time from recorded time.

The screens show existing interface states, not participant test results. The survey supports testing dose confirmation but does not validate this flow. Medication imagery did not load consistently during capture; these images retain that state.

Research-informed questions for the next iteration

The survey identifies needs; these tests will assess whether the interface meets them.

01

Fit reminders to habits

Evidence: 15/20 tie doses to a daily activity; 7/14 difficulty responses describe timing, forgetting or tracking.

Next test: Compare routine-based reminders with the existing daily grouping, including changed schedules and midday doses.

02

Make recent actions clear

Evidence: 14/20 rely on recall to check whether a dose was taken.

Existing baseline: Recording, Undo and history with planned and recorded times.

Next test: Confirm a recent dose and correct a mistaken entry; measure uncertainty, task success and logging effort.

03

Make refills visible earlier

Evidence: 19/20 refill when supply looks low; 5/14 difficulty responses describe refill logistics.

Next test: Prototype a refill overview and editable supply estimates. Check whether people notice upcoming refills and correct errors.

04

Support varied ways of managing

Evidence: Six of 18 travel responses mention an organizer; 12/21 report no current help from others.

Next test: Include organizer users and people using no app. Evaluate optional support, keyboard access, screen readers and text enlargement separately.

04 / CURRENT OUTCOME

An existing prototype.
A clearer research direction.

Dose now combines an AI-built interactive prototype with an exploratory user study: 21 completed survey responses, synthesized in the 13 October 2026 report. I originated the concept, inspiration and research collection; AI produced the app and interface build.

What has been built

A working exploration of schedules, dose recording, correction and history, with documented navigation and interface captures.

What has been learned

Respondents rely on routines and memory. Timing disruptions and refill logistics recur in written answers. These findings prioritize habit-based reminders, visible dose history and refill planning.

What remains to be demonstrated

A revised flow that meets those needs with little effort. The survey has not established usability, app demand, accessibility outcomes or improved medication adherence.

The research is exploratory and question-level samples vary. The screenshots predate the report; a completed research-informed redesign or usability-tested improvement is not claimed.

Explore the prototypeRead the full research report
05 / USER RESEARCH

Everyday habits.
Shared points of friction.

An exploratory survey produced 21 completed responses and 4 incomplete records. The 13 October 2026 report describes existing habits and difficulties; it is not a usability test of Dose. Question-level samples vary. These three slides connect the findings to priorities for the next iteration.

EXISTING HABITS01 / 03

Routines and memory
carry the daily workload

75%

Anchor doses to a routine

15 / 20 respondents

  • Meals, waking and bedtime are familiar cues.
70%

Rely on recall to check a dose

14 / 20 respondents

  • A recent-action record could reduce uncertainty.
95%

Refill when supply looks low

19 / 20 respondents

  • Earlier visibility is a hypothesis to test.

Each question: n=20 · Multiple selections allowed · Only 2/20 use a medication app for reminders; future interest was not established.

COMMON FRICTION02 / 03

Disrupted routines
and refill logistics recur

65%

Forgot at least one dose
in the past 30 days

13 of 20 · 6 none · 1 could not recall

Primary difficulty themes

14 written answers · one category per answer

Timing, forgetting & tracking
7/14 · 50%
Refill scheduling & pharmacy access
5/14 · 36%
Organizer portability
1/14 · 7%
No difficulty reported
1/14 · 7%
  • Changed schedules, midday doses and separate refill dates interrupt routines.

Forgetting: n=20 · Themes: Q15, n=14, coded by one analyst · These groups were not cross-tabulated.

COLLECTED NEEDS → DESIGN PRIORITIES03 / 03

Fit the routine.
Make the next action visible.

Needs inferred from the findings; proposed features still require testing.

  1. 01

    Remember & confirm

    • Flexible reminders tied to existing habits.
    • A quick way to check recent doses.
    VALIDATE

    Can people confirm a dose with less uncertainty and little logging effort?

  2. 02

    Plan refills ahead

    • See separate refill dates together.
    • Adjust supply estimates and lead-time alerts.
    VALIDATE

    Can people spot an upcoming refill and correct inaccurate estimates?

  3. 03

    Stay supported when plans change

    • Support travel, busy days and organizers.
    • Test optional help from another person.
    VALIDATE

    Does the flow work outside the usual routine? Test support access separately.

Priorities for prototype validation · Findings do not establish market demand, clinical benefit or pharmacy-integration demand.

Exploratory convenience sample, mostly recruited through social media. Findings describe these respondents; they are not representative of Canada.

view detailed report
06 / ITERATIONRESEARCH → DESIGN DECISIONS

Less uncertainty. More everyday confidence.

21 completed survey responses shaped 14 priorities for the next Dose prototype.

01 / FIRST PRIORITYCRITICAL
65%

forgot at least one dose
in the past 30 days13 / 20 respondents

A safer next step

Dedicated missed-dose support points to stored prescription instructions or a pharmacy.

Prescription instructions → Pharmacy contactNo universal take-or-skip rule.
0270%14 / 20 respondents
Rely on recall

Make recent actions visible

Exact time + Undo on Home.
A fast, chronological “Did I take it?” history.

0375%15 / 20 respondents
Use routine cues

Build around existing habits

Waking, meals and bedtime groups.
Keep the clock time visible.

04–0695%19 / 20 respondents
Refill when supply looks low

Bring refill planning forward

Separate dates + correctable supply estimates.
Optional alerts before supply runs out.

SUPPORTING CHANGESPRIORITIES 07–14
07–09

Make room for real life

Adjust today only; tomorrow stays usual.
Distinguish late, skipped and taken doses.

10–11

Keep support close

55% consult labels first (11 / 20).
Keep label details + pharmacy contacts nearby.
Make logging quick and optional.

12–14

Keep people in control

Optional, permission-based support access.
Support complex regimens and refill dates.
Preserve accessibility and existing features.

Source: Medication Research Report · 13 Oct 2026 · 21 completed responses; percentage questions n=20.
Exploratory findings inform design priorities. Usability and clinical outcomes remain unvalidated.

07 / PROTOTYPE V2

Prototype v2.

Phase Two · Planned

Planned: bring the research-informed changes into a second prototype. Screens and an updated prototype link will be added when available.

08 / NEXT STEPS

Refine from the findings.
Then test the experience.

The exploratory survey is complete for this report. The next phase is to clarify the findings, wireframe the priority flows, update the prototype and run usability sessions. These are planned activities, not completed results.

1 / Clarify & wireframe

Follow up with 6–8 adults with varied routines, digital confidence and access needs. Explore reminder timing, recent-dose checks and refill coordination. Sketch alternatives before refining the interface.

2 / Prototype & test

Use fictional medication data to test dose confirmation and correction, upcoming refills, editable estimates, travel and a busy midday schedule. Include organizer users and people who currently use no app.

3 / Measure & iterate

Record task success, uncertainty, logging burden and refill-estimate corrections. Prioritize observed failures, retest changes and document what improved and what remains unresolved.

Acceptance questions tied to the research
  • Can participants fit reminders to an existing routine and handle a changed schedule?
  • Can they confirm a recent dose, distinguish planned from recorded time and recover from an incorrect entry?
  • Can they spot a refill early enough and correct an inaccurate supply estimate?
  • Does the flow work with an organizer, during travel and without assistance?

These questions assess the proposed experience; they are not measured outcomes or clinical claims.

Accessibility, support and service checks

Check contrast, keyboard order, visible focus, screen-reader labels and state announcements, 200% text enlargement, reduced motion and touch targets. Include participants who use relevant access methods where possible.

Validate support-person permissions, consent, revocation and editing separately. Verify reminder delivery, time handling, offline behaviour and recovery independently of interface appearance. The survey does not demonstrate demand for pharmacy integration.

For missed doses, test a clear status and access to existing prescription instructions or pharmacist contact. Do not infer a universal dosing or rescheduling rule from reported behaviours.

Document recruitment, participant counts, tasks and limitations. A before-and-after claim will require an observed iteration and retest; no improved adherence or lower error rate has been measured.

Next project: Northern HospitalityReturn to research findings
09 / USABILITY TESTING

Usability Testing.

Phase Three · Planned

Planned: test the revised experience with users. Tasks, observations and findings will be added after the sessions.

10 / ITERATION

Iteration.

Phase Three · Planned

Planned: refine the experience in response to usability testing. This slide will document the changes and what prompted them.

11 / PROTOTYPE V3

Prototype v3.

Phase Three · Planned

Planned: bring the usability-informed changes into a third prototype. Screens and an updated prototype link will be added when available.